News | March 16, 2022
Bharat Biotech and Biofabri to develop and distribute novel TB vaccine
MTBVAC is a global public-private project that will be a milestone in the field of vaccinology
MTBVAC is a global public-private project that will be a milestone in the field of vaccinology
Ritonavir oral tablet is a pharmacokinetic booster of multiple oral antiviral drugs targeting viral proteases and a component of the approved oral antiviral drug Paxlovid (Nirmatrelvir 300 mg tablet + ritonavir 100 mg tablet co-administration package)
Brazil has the 4th largest pet market in the world with an estimated market size of BRL 1.8 billion, growing annually at 16%
Collaboration aims to evolve precision medicine with cell-specific delivery of gene therapy
First Positive Study for KEYTRUDA in Adjuvant Stage IB-IIIA NSCLC
CuraTeQ and Orion had entered into a licensing agreement, granting marketing and distribution rights for CuraTeQ’s biosimilar products under development in the Nordic states, Austria, Hungary and Slovenia
The European Commission (EC) granted marketing authorisation for Celltrion’s regdanvimab following a positive opinion by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) last week
Transformational partnership establishes PCI as a CDMO and broadens capabilities across drug product lifecycle
The CASPIAN Phase III trial in extensive-stage small-cell lung cancer is the longest survival follow-up ever reported for immunotherapy treatment in this setting
The company has already embarked upon significant expansion in Turkey
Subscribe To Our Newsletter & Stay Updated
